Skip to content

Computerized Contraceptive Decision Aid

Randomized Clinical Trial of a Computerized Contraceptive Decision Aid

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01479985
Acronym
CDM RCT
Enrollment
253
Registered
2011-11-28
Start date
2014-01-31
Completion date
2015-07-31
Last updated
2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception, Decision Making, Evaluation, Satisfaction

Brief summary

The purpose of this study is to conduct a randomized clinical trial of a web-based contraceptive decision aid compared to routine contraceptive counseling to evaluate the effect of the contraceptive decision aid on the contraceptive method selected by the participant. The investigators primary hypothesis is that women utilizing a computerized Contraceptive Decision Aid (CDA) will be more likely to choose highly effective contraception than women who undergo standard clinical contraceptive counseling.

Detailed description

Our primary specific aim is to test the CDA by conducting a randomized clinical trial comparing the CDA to routine contraceptive counseling. Our primary outcome of interest will be selection of highly effective contraception including the intrauterine device (IUD), the implant, and injectable contraception compared to all other reversible contraceptive methods. We will also complete the following secondary specific aims: 1. We will use the validated Decisional Conflict Scale to measure decisional conflict pre- and post-intervention and compare the change in decisional conflict score in women randomized to the CDA to women undergoing routine counseling. 2. We will also evaluate satisfaction with contraceptive counseling and contraceptive continuation and satisfaction at 3 and 6 months.

Interventions

OTHERCDM Tool

Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers

Sponsors

Society of Family Planning
CollaboratorOTHER
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 18-45 years old * At risk for unintended pregnancy and seeking reversible contraception at Center of Advanced Medicine or Washington University Resident's Clinic * Willing and able to complete Contraceptive Decision Making tool * English speaking

Exclusion criteria

* Have had a hysterectomy, bilateral oophorectomy, have undergone female sterilization * Unable to give informed consent secondary to language barrier or cognitive limitation

Design outcomes

Primary

MeasureTime frameDescription
Decisional Conflict Scale ScorePre-Visit and Post-Visit (same day)Pre-Visit, Post-Visit and change in Decisional Conflict Scale (DCS) Score between Post-Visit (immediately following visit) and Pre-Visit (immediately prior to visit). The Decisional Conflict Scale scores range from 0 to 100; 0 represents no decisional conflict and 100 represents high decisional conflict.

Secondary

MeasureTime frameDescription
Contraceptive Method ChosenPost-visit (immediately after visit)Contraceptive method chosen at end of visit with healthcare provider as reported on the post-visit survey

Participant flow

Participants by arm

ArmCount
CDM Tool
participants will be randomized to completing the CDM tool CDM Tool: Participants will be required to complete the CDM tool and receive a tailored print out of their contraceptive options based on survey answers
166
Control
Participants will fill out a computer survey similar to CDM tool without the decisive factors and computer print out
85
Total251

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyNo decisional conflict scale responses02
Overall StudyNo post-visit survey53
Overall StudyTablet malfunction, no data saved11

Baseline characteristics

CharacteristicCDM ToolControlTotal
Age, Continuous28.5 years
STANDARD_DEVIATION 6.2
28.4 years
STANDARD_DEVIATION 6.2
28.5 years
STANDARD_DEVIATION 6.2
Race/Ethnicity, Customized
Black
62 Participants23 Participants85 Participants
Race/Ethnicity, Customized
Other
20 Participants7 Participants27 Participants
Race/Ethnicity, Customized
White
84 Participants55 Participants139 Participants
Region of Enrollment
United States
166 participants85 participants251 participants
Sex: Female, Male
Female
166 Participants85 Participants251 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1670 / 86
other
Total, other adverse events
0 / 1670 / 86
serious
Total, serious adverse events
0 / 1670 / 86

Outcome results

Primary

Decisional Conflict Scale Score

Pre-Visit, Post-Visit and change in Decisional Conflict Scale (DCS) Score between Post-Visit (immediately following visit) and Pre-Visit (immediately prior to visit). The Decisional Conflict Scale scores range from 0 to 100; 0 represents no decisional conflict and 100 represents high decisional conflict.

Time frame: Pre-Visit and Post-Visit (same day)

Population: 8 subjects did not complete the post-visit survey, so a post-visit DCS score and change in DCS score could not be calculated

ArmMeasureGroupValue (MEDIAN)
CDM ToolDecisional Conflict Scale ScorePre-Visit Score15 score on a scale
CDM ToolDecisional Conflict Scale ScorePost-Visit Score0 score on a scale
CDM ToolDecisional Conflict Scale ScoreChange in Score-10 score on a scale
ControlDecisional Conflict Scale ScorePre-Visit Score10 score on a scale
ControlDecisional Conflict Scale ScorePost-Visit Score0 score on a scale
ControlDecisional Conflict Scale ScoreChange in Score-10 score on a scale
Secondary

Contraceptive Method Chosen

Contraceptive method chosen at end of visit with healthcare provider as reported on the post-visit survey

Time frame: Post-visit (immediately after visit)

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
CDM ToolContraceptive Method ChosenImplant9 Participants
CDM ToolContraceptive Method ChosenVaginal ring8 Participants
CDM ToolContraceptive Method ChosenCopper IUD9 Participants
CDM ToolContraceptive Method ChosenSterilization0 Participants
CDM ToolContraceptive Method ChosenDMPA19 Participants
CDM ToolContraceptive Method ChosenCondoms7 Participants
CDM ToolContraceptive Method ChosenLNG-IUS45 Participants
CDM ToolContraceptive Method ChosenOther1 Participants
CDM ToolContraceptive Method ChosenPills57 Participants
CDM ToolContraceptive Method ChosenNo method/undecided5 Participants
CDM ToolContraceptive Method ChosenContraceptive patch1 Participants
ControlContraceptive Method ChosenNo method/undecided2 Participants
ControlContraceptive Method ChosenContraceptive patch0 Participants
ControlContraceptive Method ChosenLNG-IUS21 Participants
ControlContraceptive Method ChosenCopper IUD3 Participants
ControlContraceptive Method ChosenImplant6 Participants
ControlContraceptive Method ChosenDMPA4 Participants
ControlContraceptive Method ChosenPills29 Participants
ControlContraceptive Method ChosenVaginal ring5 Participants
ControlContraceptive Method ChosenSterilization3 Participants
ControlContraceptive Method ChosenCondoms4 Participants
ControlContraceptive Method ChosenOther3 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026